ÌÇÐÄÊÓÆµ

Christopher Walkey

Walkey

Christopher Walkey, Ph.D.

Education

BSc from Simon Fraser University
12/1992 - Burnaby, BC, Canada
Biochemistry
PhD from University of Alberta
06/1998 - Edmonton, AB, Canada
Postdoctoral Fellowship at Dana-Farber Cancer Insitute and Harvard Medical School
Boston, Massachusetts, United States

Professional Interests

  • Somatic genome editing
  • Gene therapy and vector development
  • Lipid and lipoprotein metabolism

Selected Publications

  • Walkey CJ, Lagor WR. " " J Cardiovasc Aging. 2023 Mar ; 3 (2) : 19.
    Pubmed PMID: .
  • Huang Q, Chen AT, Chan KY, Sorensen H, Barry AJ, Azari B, Zheng Q, Beddow T, Zhao B, Tobey IG, Moncada-Reid C, Eid F, Walkey CJ, Ljungberg MC, Lagor WR, Heaney JD, Chan YA, Deverman BE. " Targeting AAV vectors to the central nervous system by engineering capsid-receptor interactions that enable crossing of the blood-brain barrier. " PLOS Biology. 2023 May ; in press
  • Lorincz R, Alvarez AB, Walkey CJ, Mendonça SA, Lu ZH, Martinez AE, Ljungberg C, Heaney JD, Lagor WR, Curiel DT. " " Biomed Pharmacother. 2023 Feb ; 158 : 114189.
    Pubmed PMID: .
  • Phillips E, Ahmad N, Sun L, Iben J, Walkey CJ, Rusin A, Yuen T, Rosen CJ, Willis IM, Zaidi M, Johnson DL. " " eLife. 2022 May ; 11 : e74740.
    Pubmed PMID: .

Memberships

American Society for Gene and Cell Therapy

to edit your profile